Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Syncromune at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Syncromune exhibits at Booth 1201 at SITC 2026 in Phoenix, and takes part in 1 session. Its presence centres on new immunotherapy agents. Syncromune is developing SYNC-T, a personalized treatment given inside the tumor that partly destroys it and adds a biologic hitting several targets to switch on T cells.

OrganizationSITC 2026 Attendance
Syncromune
Fort Lauderdale, FL
syncromune.com
Biotech
Private clinical-stage company developing SYNC-T, a personalized in situ therapy pairing partial tumor oncolysis with a multi-target biologic to activate T cells.
Booth
Exhibiting at Booth 1201
Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm
Workshop
Fri Nov 6
12:30pm–1:30pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Syncromune

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction